Business Context and Reporting Period
This Form 8-K filing by Intrexon Corporation (not Precigen, Inc.) reports a material definitive agreement entered into on January 21, 2015. The report was filed on January 22, 2015, regarding a public offering of common stock.
Key Financial Metrics
- Shares Offered: 3,750,000 shares of common stock.
- Offering Price: $27.00 per share to the public.
- Net Proceeds: Approximately $95.8 million expected after deducting underwriting discounts, commissions, and estimated offering expenses.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 562,500 shares at the offering price.
- Expected Closing Date: On or about January 27, 2015.
Material Changes
The primary material change is the execution of an underwriting agreement for a new equity offering. This represents a significant capital raise event distinct from prior periods, intended to increase the company's cash liquidity. The filing does not provide comparative financial data (revenue, profit, or margins) as it is a current report on a specific transaction rather than a periodic financial statement.
Guidance, Outlook, and Risks
The offering is subject to the satisfaction of customary closing conditions. The underwriting agreement includes customary representations, warranties, indemnification provisions, and termination clauses. The company is utilizing an automatic shelf registration statement (Form S-3ASR) filed on September 5, 2014. No specific forward-looking guidance on revenue or earnings was included in this specific filing text.
Important Facts for Investor Verification
- Verify the final closing date and whether the over-allotment option was exercised.
- Confirm the actual net proceeds received after all expenses are finalized.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific lock-up periods or restrictive covenants.
- Check subsequent filings to determine how the raised capital is being deployed.